Hemoadsorption/Hemodialysis: Current Evidence and Outcome on Uremic Toxin Removal and Symptom Improvement
Contributions to Nephrology · 2026
DOI: 10.1159/000552913 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Contributions to Nephrology, 2026. Verfasst von Mario Cozzolino und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Milan, Renal Division, ASST Santi Paolo e Carlo, Milan, Italy, mario.cozzolino@unimi.it. Hauptthemen laut MEDLINE: Renal Dialysis, Uremic Toxins, Uremia.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences, University of Milan, Renal Division, ASST Santi Paolo e Carlo, Milan, Italy, mario.cozzolino@unimi.it.
- Department of Health Sciences, University of Milan, Renal Division, ASST Santi Paolo e Carlo, Milan, Italy.
Zitieren
APA
Cozzolino, M., Magagnoli, L., & Ciceri, P. (2026). Hemoadsorption/Hemodialysis: Current Evidence and Outcome on Uremic Toxin Removal and Symptom Improvement. Contributions to Nephrology. https://doi.org/10.1159/000552913
Vancouver
Cozzolino M, Magagnoli L, Ciceri P. Hemoadsorption/Hemodialysis: Current Evidence and Outcome on Uremic Toxin Removal and Symptom Improvement. Contributions to Nephrology. 2026. doi:10.1159/000552913
BibTeX
@article{Cozzolino2026,
author = {Cozzolino, Mario and Magagnoli, Lorenza and Ciceri, Paola},
title = {Hemoadsorption/Hemodialysis: Current Evidence and Outcome on Uremic Toxin Removal and Symptom Improvement},
journal = {Contributions to Nephrology},
year = {2026},
doi = {10.1159/000552913}
}
EUVIMED